Når symptomerne er under kontrol, kan vedligeholdelsesdosis muligvis reduceres til 1 pust i hvert næsebor (døgndosis i alt 55 mikrogram).
Once adequate control of symptoms is achieved, dose reduction to one spray actuation in each nostril (total daily dose 55 micrograms) may be effective for maintenance.